Epidemiology of XXXX in Poland in urban and rural areas, based on provided health care services.

@entity1 @entity565 @entity4862
INTRODUCTION: @entity565 is a serious health and social problem, also in Poland. The epidemiological data indicate that the problem of @entity565 concerns approximately 4 million @entity1 in Poland, whereas almost approximately 70% of them have no diagnosis and are not aware of their illness, and on the other hand in 39% of @entity1 who declared the diagnosis of @entity565 in a survey the diagnosis was negatively verified (overdiagnosis of @entity565 ). So far, no detailed comparative studies for @entity565 incidence rate in urban and rural areas were conducted in Poland. The aim of the study was to analyze @entity1 with @entity565 in Poland in the years 2008-2012, with regard to province and type of commune (rural/urban). MATERIAL AND METHODS: The study used data from National Health Fund (NFZ) - reported by health care providers regarding the @entity1 diagnosed with @entity565 . Using structured query language (SQL) a set of @entity1 was selected and created, for whom at the same time ICD-10 code: J45.X-bronchial @entity565 was reported. In order to estimate the number of @entity1 with @entity565 we used the PESEL social security number as a unique identifier of the @entity1 . Code of the @entity1 ' @entity4862 of residence in conjunction with the Central Statistical Office data formed the basis for the division of municipalities into urban and rural areas. The analysis of @entity565 incidence trends in Poland was performed on the basis of health services provided to @entity1 . The analysis was performed by using the Statistica 10 software using a negative binomial regression model. RESULTS: In 2009 a significant increase in the number of @entity1 with @entity565 was observed compared with the previous year, whereas after 2009 the number of @entity1 diagnosed with @entity565 remained relatively constant. A significant increase of predominance of @entity1 among @entity565 @entity1 in recent years can be noticed: from 107% in 2008 to almost 115% in 2012 (F:M ratio). Regardless of the analyzed year and the diagnosis the incidence rate remained constant: approximately 55-57% for urban areas and about 43-45% in rural areas. CONCLUSIONS: The average prevalence rate for rural areas is significantly lower than for urban areas. The use of adjusted incidence rate leads to the conclusion that the number of sufferers in urban areas is higher (about 10%) of the number of sufferers in the rural areas. The results of the analysis are consistent with information from previous studies in Poland and in the world.
